Testosterone butyrate

From WikiProjectMed
Jump to navigation Jump to search
Testosterone butyrate
Clinical data
Routes of
administration
Intramuscular injection
Identifiers
  • [(8R,9S,10R,13S,14S,17S)-10,13-Dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] butanoate
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
ECHA InfoCard100.020.270 Edit this at Wikidata
Chemical and physical data
FormulaC23H34O3
Molar mass358.522 g·mol−1
3D model (JSmol)
  • CCCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C
  • InChI=1S/C23H34O3/c1-4-5-21(25)26-20-9-8-18-17-7-6-15-14-16(24)10-12-22(15,2)19(17)11-13-23(18,20)3/h14,17-20H,4-13H2,1-3H3/t17-,18-,19-,20-,22-,23-/m0/s1
  • Key:OMPTUWYLCDEFSJ-WAUHAFJUSA-N

Testosterone butyrate, or testosterone butanoate, also known as androst-4-en-17β-ol-3-one 17β-butanoate, is a synthetic, steroidal androgen and an androgen ester – specifically, the C17β butanoate ester of testosterone – which was first synthesized in the 1930s and was never marketed.[1][2][3][4] Its ester side-chain length and duration of effect are intermediate between those of testosterone propionate and testosterone valerate.[2]

Parenteral durations of androgens/anabolic steroids
Medication Form Major brand names Duration
Testosterone Aqueous suspension Andronaq, Sterotate, Virosterone 2–3 days
Testosterone propionate Oil solution Androteston, Perandren, Testoviron 3–4 days
Testosterone phenylpropionate Oil solution Testolent 8 days
Testosterone isobutyrate Aqueous suspension Agovirin Depot, Perandren M 14 days
Mixed testosterone estersa Oil solution Triolandren 10–20 days
Mixed testosterone estersb Oil solution Testosid Depot 14–20 days
Testosterone enanthate Oil solution Delatestryl 14–28 days
Testosterone cypionate Oil solution Depovirin 14–28 days
Mixed testosterone estersc Oil solution Sustanon 250 28 days
Testosterone undecanoate Oil solution Aveed, Nebido 100 days
Testosterone buciclated Aqueous suspension 20 Aet-1, CDB-1781e 90–120 days
Nandrolone phenylpropionate Oil solution Durabolin 10 days
Nandrolone decanoate Oil solution Deca Durabolin 21–28 days
Methandriol Aqueous suspension Notandron, Protandren 8 days
Methandriol bisenanthoyl acetate Oil solution Notandron Depot 16 days
Metenolone acetate Oil solution Primobolan 3 days
Metenolone enanthate Oil solution Primobolan Depot 14 days
Note: All are via i.m. injection. Footnotes: a = TP, TV, and TUe. b = TP and TKL. c = TP, TPP, TiCa, and TD. d = Studied but never marketed. e = Developmental code names. Sources: See template.

See also

References

  1. ^ Yalkowsky SH, He Y, Jain P (19 April 2016). Handbook of Aqueous Solubility Data (Second ed.). CRC Press. pp. 1288–. ISBN 978-1-4398-0246-5.
  2. ^ a b Dorfman RI, Shipley RA (1956). Androgens: biochemistry, physiology, and clinical significance. Wiley. p. 119.
  3. ^ Koch FC (January 1937). "Recent advances in the field of androgens". Cold Spring Harbor Symposia on Quantitative Biology. 5. Cold Spring Harbor Laboratory Press: 34–43. doi:10.1101/SQB.1937.005.01.004.
  4. ^ Griffiths PJ, James KC, Rees M (1965). "Crystallographic data for some testosterone esters". Acta Crystallographica. 19 (1): 149–150. Bibcode:1965AcCry..19..149G. doi:10.1107/S0365110X65002918. ISSN 0365-110X.